The second anti-coronavirus disease vaccine from Serum Institute Life Sciences (SILS), a new company floated by SII, is likely to be Covovax, which is a spike protein vaccine being developed in association with biotech firm Novovax. Read More
reported by hindustantimes.com | Edited by Meenakshi Ray at Hindustan Times
Recent Comments